GOSS

Gossamer Bio, Inc. Common Stock
Data: 2026-08-03

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Quick Stats
Aug 03, 2026

59.8

AI Score

HOLD

0.5

Volume Ratio

Aug 04, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

GOSS Stock Summary

Last updated Aug 03, 2026

GOSS is currently trading at $0.1736, positioned below its 200-day moving average of $1.38, suggesting bearish momentum. The stock has a 52-week range of $0.1138 to $3.87.

Technical Analysis: The 50-day moving average stands at $0.18, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.456, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.063, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GOSS at 59.8/100 with a HOLD recommendation.

GOSS (Gossamer Bio, Inc. Common Stock) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 48.456
CMF (20) 0.063
ROC (10) 19.574
ADX (14) 23.036
Indicator Value
MACD (12,26,9) -0.001
AROONOSC (14) 71.429
WILLAMS %R (14) -70.688
MFI (14) 79.193
GOSS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

GOSS Price vs Max Options Open Interest
GOSS Max Change In Options Open Interest

GOSS Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GOSS Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GOSS Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GOSS Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Gossamer Bio, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

GOSS Moving Averages Analysis

GOSS (Gossamer Bio, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 0.17
20 0.17
30 0.17
50 0.18
100 0.27
200 1.38

GOSS Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 82.9 million
Earnings/Share ($) -0.79
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.3689
EPS Estimate Next Year ($) -0.0937
WallStreet Target Price ($) 3.86
Most Recent Quarter